HealthQuill Women's Health
India’s Mankind Pharma will buy Mumbai-based Bharat Serums and Vaccines for 136 billion rupees ($1.63 billion), according to a company statement.
Drugs Health Pharma

Mankind Pharma buys Bharat Serum and Vaccines for $1.6 billion

India’s Mankind Pharma will buy Mumbai-based Bharat Serums and Vaccines for 136 billion rupees ($1.63 billion), according to a company statement.

Read More
The US health regulator has approved a drug of Utility Therapeutics to treat adult women, 18 years or older, with “uncomplicated” urinary tract infections.
Drugs Health Pharma

Utility Therapeutics gets FDA nod for drug to fight urinary tract infections

HQ Team April 25, 2024: The US health regulator has approved a drug of Utility Therapeutics to treat adult women, 18 years or.

Read More
Physicians and scientists are on the lookout for a new non-invasive diagnostic process for a lesser-known condition called adenomyosis in women.
Drugs Health Pharma

Scientists’ eye easy diagnosis for adenomyosis condition in women

Physicians and scientists are on the lookout for a new non-invasive diagnostic process for a lesser-known condition called adenomyosis in women.

Read More
Nuvectis Pharma, Inc., a US biopharmaceutical firm, has started its experimental trial in humans to treat solid tumors.
Drugs Health Pharma

US-based Nuvectis Pharma starts human trial on solid tumors

HQ Team September 12, 2023: Nuvectis Pharma, Inc., a US biopharmaceutical firm, has started its experimental trial in humans to treat solid tumors..

Read More
Astellas Pharma, a Japanese drugmaker, announced that the FDA has approved its oral drug Veozah for the treatment of hot flushes in menopausal women.
Drugs Health Pharma

Astellas drug to treat menopausal hot flashes gets FDA’s green light

HQ Team May 14, 2023: Astellas Pharma, a Japanese drugmaker, announced that the FDA has approved its oral drug Veozah for the treatment.

Read More
X